Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|July 17, 2014
Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWPA Bazarbachi, K Cwynarski, A Boumendil, et al.
Leukemia|May 1, 2014
Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysisM Stern, L C de Wreede, R Brand, et al.
Experimental Hematology|October 12, 2000
A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemiaP Dreger, K Viehmann, N von Neuhoff, et al.
Bone Marrow Transplantation|February 1, 1995
Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantationN Schmitz, P Dreger, A R Zander, et al.
Lancet (London, England)|February 10, 1996
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patientsN Schmitz, D C Linch, P Dreger, et al.
Leukemia|April 15, 2005
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysisP Dreger, R Brand, D Milligan, et al.
Leukemia|April 18, 2008
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trialM Ritgen, S Böttcher, S Stilgenbauer, et al.
Blood|November 1, 1996
Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantationH H Euler, A M Marmont, A Bacigalupo, et al.
Leukemia|July 19, 2014
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphomaS Robinson, P Dreger, D Caballero, et al.
Bone Marrow Transplantation|August 24, 1999
Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recoveryP Dreger, K Viehmann, N von Neuhoff, et al.
Pageof 12